Concepedia

John Radford

JR

229

Publications

24.9K

Citations

80

H-Index

1985

Active since

Affiliations

University of Manchester(Current)

The Christie NHS Foundation Trust

Cancer Research UK

The Christie Hospital

Manchester Academic Health Science Centre

John Radford is an author at University of Manchester specializing in medicine, oncology, and pathology.

ORCID

Top concepts

Publications per year

1985–2023

229

Publications

229

Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma

Michael Wang, Simon Rule, Peter Martin et al. · New England Journal of Medicine · 2013 · 1.7K citations · Full text

Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma

Robert Chen, Pier Luigi Zinzani, Michelle A. Fanale et al. · Journal of Clinical Oncology · 2017 · 967 citations · Full text

, , +18

Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicenter phase II study.

B. Coiffier, Corinne Haïoun, Nicolas Ketterer et al. · PubMed · 1998 · 896 citations

Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin’s Lymphoma

Peter Johnson, Massimo Federico, Amy A. Kirkwood et al. · New England Journal of Medicine · 2016 · 778 citations · Full text

Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin’s Lymphoma

Joseph M. Connors, Wojciech Jurczak, David J. Straus et al. · New England Journal of Medicine · 2017 · 738 citations · Full text

Rows per page

1–5 of 229